Fitness Trade-Offs between Phage and Antibiotic Sensitivity in Phage-Resistant Variants: Molecular Action and Insights into Clinical Applications for Phage Therapy
International Journal of Molecular Sciences · 26.10.2023 · 24 (21) · 15628
DOI: 10.3390/ijms242115628 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.10.2023. Verfasst von Jumpei Fujiki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Biochemistry, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu 069-8501, Japan. Hauptthemen laut MEDLINE: Bacteriophages, Phage Therapy, Bacterial Infections. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEXT/JSPS KAKENHI.
Abstract (Originalsprache)
In recent decades, phage therapy has been overshadowed by the widespread use of antibiotics in Western countries. However, it has been revitalized as a powerful approach due to the increasing prevalence of antimicrobial-resistant bacteria. Although bacterial resistance to phages has been reported in clinical cases, recent studies on the fitness trade-offs between phage and antibiotic resistance have revealed new avenues in the field of phage therapy. This strategy aims to restore the antibiotic susceptibility of antimicrobial-resistant bacteria, even if phage-resistant variants develop. Here, we summarize the basic virological properties of phages and their applications within the context of antimicrobial resistance. In addition, we review the occurrence of phage resistance in clinical cases, and examine fitness trade-offs between phage and antibiotic sensitivity, exploring the potential of an evolutionary fitness cost as a countermeasure against phage resistance in therapy. Finally, we discuss future strategies and directions for phage-based therapy from the aspect of fitness trade-offs. This approach is expected to provide robust options when combined with antibiotics in this era of phage ‘re’-discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Veterinary Biochemistry, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu 069-8501, Japan.
- Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
- Phage Therapy Institute, Waseda University, Tokyo 169-8050, Japan.
- Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.
- Department of Veterinary Medicine, Azabu University, Sagamihara 252-5201, Japan.
ORCID-Profile: Jumpei Fujiki, Hidetomo Iwano
Förderung
- MEXT/JSPS KAKENHI
Zitieren
APA
Fujiki, J., Nakamura, K., Nakamura, T., & Iwano, H. (2023). Fitness Trade-Offs between Phage and Antibiotic Sensitivity in Phage-Resistant Variants: Molecular Action and Insights into Clinical Applications for Phage Therapy. International Journal of Molecular Sciences, 24(21), 15628. https://doi.org/10.3390/ijms242115628
Vancouver
Fujiki J, Nakamura K, Nakamura T, Iwano H. Fitness Trade-Offs between Phage and Antibiotic Sensitivity in Phage-Resistant Variants: Molecular Action and Insights into Clinical Applications for Phage Therapy. International Journal of Molecular Sciences. 2023;24(21):15628. doi:10.3390/ijms242115628
BibTeX
@article{Fujiki2023,
author = {Fujiki, Jumpei and Nakamura, Keisuke and Nakamura, Tomohiro and Iwano, Hidetomo},
title = {Fitness Trade-Offs between Phage and Antibiotic Sensitivity in Phage-Resistant Variants: Molecular Action and Insights into Clinical Applications for Phage Therapy},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {21},
pages = {15628},
doi = {10.3390/ijms242115628}
}
EUVIMED